Omeros Corporation
(NASDAQ : OMER)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.43%198.251.2%$509.50m
GILDGilead Sciences, Inc.
-0.07%73.540.9%$446.75m
BIIBBiogen Inc.
-0.26%330.101.3%$367.66m
CELGCelgene Corporation
0.07%82.641.2%$330.69m
ILMNIllumina, Inc.
-1.51%316.853.5%$286.08m
REGNRegeneron Pharmaceuticals, Inc.
-1.44%378.632.6%$220.72m
ALXNAlexion Pharmaceuticals, Inc.
0.62%122.702.0%$210.04m
VRTXVertex Pharmaceuticals Incorporated
-1.24%179.071.9%$200.96m
SRPTSarepta Therapeutics, Inc.
0.61%131.3016.4%$167.44m
AAgilent Technologies, Inc.
-0.09%66.181.5%$154.41m
BMRNBioMarin Pharmaceutical Inc.
0.91%100.424.4%$129.52m
LGNDLigand Pharmaceuticals Incorporated
-0.51%201.5623.3%$107.59m
VKTXViking Therapeutics, Inc.
-2.35%14.120.9%$106.20m
NKTRNektar Therapeutics
0.27%49.045.6%$105.75m
NBIXNeurocrine Biosciences, Inc.
-0.70%110.705.1%$96.30m

Company Profile

Omeros Corp. operates as a biopharmaceutical company specializes in discovery, development, and commercializes of both small-molecule and protein therapeutics for large -market as well as orphan indications targeting inflammation, coagulopathies and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.